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1. Introduction 
Lactic acid bacteria (LAB) are widespread microorganisms which can be found in any 
environment rich mainly in carbohydrates, such as plants, fermented foods and the mucosal 
surfaces of humans, terrestrial and marine animals. In the human and animal bodies, LAB 
are part of the normal microbiota or microflora, the ecosystem that naturally inhabits the 
gastrointestinal and genitourinary tracts, which is comprised by a large number of different 
bacterial species with a diverse amount of strains [1,2].  
Phylogenetically the LAB belong to the Clostridium branch of Gram positive bacteria. They 
are non-sporing, aero tolerant anaerobes that lack catalase and respiratory chain, with a 
DNA base composition of less than 53 mol% G+C [3,4]. According to their morphology LAB 
are divided to robs and cocci and according to the mode of glucose fermentation to 
homofermentative and heterofermentative. The homofermentative LAB convert 
carbohydrates to lactic acid as the only or major end-product, while the heterofermentative 
produce lactic acid and additional products such as ethanol, acetic acid and carbon dioxide 
[5,6]. Thus, the main metabolism of LAB is the degradation of different carbohydrates and 
related compounds by producing primarily lactic acid and energy. Although many genera 
of bacteria produce lactic acid as primary or secondary fermentation products, typical lactic 
acid bacteria are those of the Lactobacillales order, including the following genera: 
Lactobacillus, Carnobacterium, Lactococcus, Streptococcus, Enterococcus, Vagococcus, Leuconostoc, 
Oenococcus, Pediococcus, Tetragonococcus, Aerococcus and Weissella [7]. 
Many strains of LAB are among the most important groups of microorganisms used in the 
food and feed industries, although some of the genus Pediococcus cause deterioration of 
foods, which results in their spoilage [4]. LAB have been used in food preservation and for 
the modification of the organoleptic characteristics of foods, for example flavors and texture 
[2]. Various strains of LAB [8] can be found in dairy products (yoghurt, cheese), fermented 
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meats (salami), fermented vegetables (olives, sauerkraut), sourdough bread, etc [9]. The 
European Food Safety Authority (EFSA) has stated that several LAB strains can be 
considered to have “Qualified Presumption of Safety” QPS-status [9].  
Moreover, nowadays, LAB play an important role in the industry for the synthesis of 
chemicals, pharmaceuticals, or other useful products (Figure 1). Also, the biotechnological 
production of lactic acid has recently reported that offers a solution to the environmental 
pollution by the petrochemical industry [10]. 
 
Figure 1. Uses and Functional Ingredients of Lactic Acid Bacteria 
This chapter will discuss recent applications of LAB as source of probiotics, starter cultures, 
antimicrobial agents, vitamins, enzymes and exopolysaccharides, especially those that can 
satisfy the increasing consumer’s demands for natural products and functional foods in 
relation with human health. 
2. Lactic acid bacteria as source of probiotics 
Etymologically the term probiotics is derived from the Greek “probios” which means “for 
life”. In 1974 Parker [11] defined as probiotics “organisms and substances which contribute 
to intestinal microbial balance”. Fuller in 1989 [12] defined as probiotic “a live microbial feed 
supplement which beneficially affects the host animal by improving its intestinal microbial 
balance”. Later the Food and Agriculture Organization / World Health Organization defined 
probiotic bacteria as “live microorganisms which when administered in adequate amounts 
confer a health benefit on the host” [13]. Since probiotics can colonize the gastrointestinal 
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tract and exert their beneficial effect long term, without requiring continuous medical 
intervention, they have been used for a century to treat a variety of mucosal surface 
infections (gut, vagina), but their use decreased after the appearance of antibiotics. 
However, today, probiotics are considered as an alternative solution to antibiotics due to the 
increasing spread of antibiotic resistance and the need for treatment cost reduction [14].  
Microorganisms considered as commercial probiotics are mainly of the Lactobacillus genus 
with over one hundred species recognized, for example: L. acidophilus, L. rhamnosus, L. 
reuteri, L. casei, L. plantarum, L. bulgaricus, L. delbrueckii, L. helveticus [15-17]. Lactobacilli are 
Generally Recognized As Safe (GRAS) organisms [18,19].  
Probiotic bacteria are very sensitive to many environmental stresses, such as acidity, oxygen 
and temperature [20,21] and they must fulfill some functional and physiological aspects 
such as [21,22]: a) Adherence to the intestinal epithelium and colonization of the lumen of 
the tract. b) Ability to stabilize the intestinal microbiota. c) Counteracting the action of 
harmful microorganisms. d) Production of antimicrobial substances. e) Stimulation of the 
immune response.  
There are subcategories of the general term probiotic [23,24] which are: a) Probiotic drugs: 
intended to cue, treat and prevent disease. b) Probiotic foods: food ingredients and dietary 
supplements. c) Direct-fed microbials: probiotics for animal use. d) Designer probiotics: 
genetically modified. Generally, foods containing probiotic bacteria fall in the category of 
functional foods [25]. 
2.1. Mechanism of action of probiotics 
Probiotics have multiple and diverse effects on the host. The main mechanisms of action of 
probiotic bacteria by which they improve mucosal defenses of the gastrointestinal tract 
include: 
a. Antimicrobial activity: The probiotics block the colonization of pathogenic bacteria by 
decreasing luminal pH, inhibiting bacterial invasion and adhesion to epithelial cells and 
producing antimicrobial compounds such as bacteriocins and defensins, organic acids 
and hydrogen peroxide. The interaction of LAB with the mucosal epithelial cells of the 
gastrointestinal tract and the lymphoid cells in the gut enhance the gut immune 
response against ingested pathogens [26,27]. 
b. Enhancement of mucosal barrier function against ingested pathogens: It is achieved 
with the increasing mucus production through modulation of cytoskeletal and tight 
junctional protein phosphorylation. The probiotic bacteria compete with pathogenic 
bacteria for epithelial binding sites, inhibiting the colonization of strains like Salmonella 
and E. coli [28,29]. Probiotic bacteria interact with the epithelial cells of the gut, either 
directly (via cell compounds like DNA, lipoteichoic acids and cell-surface 
polysaccharides) or indirectly (through production of bioactive metabolites) [30]. The 
enhancement of mucosal barrier function may be an important mechanism by which 
probiotics benefit the host in various diseases such as Type 1 diabetes [31,32]. 
 
Lactic Acid Bacteria – R & D for Food, Health and Livestock Purposes 592 
c. Immunomodulation: Specific strains of probiotics might influence the innate and the 
acquired immune system, thus playing an important role in human diseases. Probiotic 
bacteria may affect the epithelial cells, the dendritic cells, the monocytes / macrophages 
and the various types of lymphocytes (Natural killer cells, T-cells and T-cell 
redistribution) directly or secondarily [33,34]. This action of probiotics could be 
important for the elimination of neoplastic host cells [22]. Moreover, the effects of 
probiotics on B-lymphocytes and antibody production resulted in an increase in IgA 
secretion and the enhancement of response to vaccination [34]. Recently, it was also 
reported that probiotics can have positive effects on the respiratory system by 
preventing and reducing the severity of respiratory infections, because of an increase of 
IgA in the bronchial mucosa [35]. 
2.2. Probiotics and health 
Functional properties of probiotics have been demonstrated for various therapeutic 
applications. Nevertheless, the health benefits provided by probiotics are strain-specific, 
therefore no probiotic strain will have all proposes benefits, not even strains of the same 
species [36]. Among the LAB probiotic strains L. rhamnosus GG and L. casei Shirota have the 
strongest human health efficacy in the management of lactose intolerance, rotaviral diarrhea 
and antibiotic associated diarrhea [17]. An optimal single oral dose, based on detection of 
the bacteria in human feces is 109 bacterial colony forming units (CFU) [37], while in other 
reports 106-107 CFU / g of food are considered adequate amounts [13,17,38].  
Moreover, in animal nutrition dietary probiotics or direct fed microbials, term which is 
preferred in the USA, are able to help the maintenance of a healthy intestinal microflora. 
This microflora may serve to improve performance and health status of the animals, but also 
to suppress food born pathogens such as Salmonella and Campylobacter. These conditions are 
necessary for the production of safe meat and meat products [39]. For instance, the 
gastrointestinal tract of broilers can be colonized by ingested probiotic bacteria from the first 
days of their life, which results in shorter period for the achievement of microflora stability. 
Also, in another example the dietary inclusion of probiotics in young calves’ milk replacers 
may improve their growth performance [40].  
Some of the beneficial effects of probiotics are well established as shown in Table 1. 
 
Lactic Acid Bacteria Effects on human health References 
Lactobacillus rhamnosus GG May shorten the course of rotavirus 
causing diarrhea. 
Helps to alleviate the symptoms of 
ulcerative colitis and atopic dermatitis. 
41-45  
Lactobacillus casei Reduces the severity and duration of 
diarrhea. It can stimulate the immune 
system of the gut and alleviates the 
symptoms of Crohn’s disease 
17, 43, 46 
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Lactic Acid Bacteria Effects on human health References 
Lactobacillus acidophilus Secretes lactic acid which reduces the 
pH of the gut and inhibits the 
development of pathogens (Salmonella 
spp, E. coli). 
Reduces blood cholesterol. 
17, 46, 47 
Lactobacillus johnsonii Effective in inhibition of H. pylori and 
against inflammation 
17, 36 
Lactobacillus plantarum Produces short-chain fatty acids that 
block the generation of carcinogenic 
agents by reducing enzyme activities 
17, 36 
Lactobacillus fermentum Effective in restoration of a normal 
microflora. Effective against bacterial 
vaginosis flora 
48 
Lactobacillus reuteri Reduces the duration of diarrhea 49 
Enterococcus faecium Can reduce blood cholesterol leading 
to decreased blood pressure 
50-52 
Table 1. Lactic acid bacteria derived probiotics and human health 
LAB derived probiotics have potential health benefits in the following situations:  
1. Diarrheal diseases: 
a. Infective diarrhea. The most studied gastrointestinal condition treated by probiotics 
is acute infectious diarrhea in infants. Children represent a main target of studies 
due to the importance of limiting the spread of diseases and decreasing the need of 
antibiotics (Aureli et al. 2011). Clinical trials with LAB derived probiotics (L. 
rhamnosus GG; L. reuteri; L. casei; L. delbrueckii subsp. Bulgaricus) support the efficacy 
of these probiotics in preventing diarrhea [14,49,53], due to their direct or indirect 
interaction with the enterotoxins [54]. 
b. Antibiotic associated diarrhea. A variety of probiotic bacteria, mainly lactobacilli 
have been used in the treatment and prevention of antibiotic associated diarrhea 
[55,56]. In a recent study L. acidophilus and L. casei seemed to be effective in 
reducing the risk of development of diarrhea [57]. Nevertheless, the results 
obtained were from pilot studies, so further investigation is needed to evaluate the 
efficacy of probiotics on such disorders. 
c. Clostridium difficile associated diarrhea. C. difficile is an opportunistic pathogen 
often responsible for diarrhea in vulnerable people. L. rhamnosus GG, has 
demonstrated positive effects on treated patients [14]. 
d. Travelers diarrhea. Probiotics with Lactobacilli did not seem to be effective on such 
diarrhea, which is caused by bacteria, in particular enterotoxigenic E. coli [14,53]. 
e. Radiation induced diarrhea. Although there is little research on this subject, 
probiotics seem to be promising in decreasing radiation diarrhea [53]. 
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2. Inflammatory bowel disease 
LAB may affect positively the intestinal mobility and relieve constipation, possibly through 
a reduction of the intestinal pH [58]. 
a. Pouchitis. It is a chronic inflammation of the ileal pouch. The treatment with 
probiotics such as L. rhamnosus GG and L. acidophilus reduced the risk of pouchitis 
due to decreased mucosal inflammation [59,60]. 
b. Crohn’s disease. This disease can involve the whole gastrointestinal tract and is 
characterized by inflammatory processes occurring deeper in the tissues. Among 
other typical treatments L. rhamnosus is used aiming at decreasing the rate and the 
severity of disease after surgery [61]. 
c. Ulcerative colitis. It is an acute or chronic disease only affecting the large bowel. 
LAB probiotics (L. acidophilus) provide some promising initial indications [53]. 
3. Irritable bowel syndrome 
This term is used to describe a heterogenous group of gastrointestinal symptoms, like 
diarrhea, constipation, bloating and abdominal pain. L. plantarum strain 299V and E. faecium 
PR88 could be effective treatments against this syndrome [62,63]. 
4. Prevention of colon cancer 
The anticarcinogenic effect of probiotiocs may be attributable to a combination of 
mechanisms like the induction of pro- or anti-inflammatory and secretary responses that 
could inhibit carcinogenesis [22]. In vitro studies with lactobacillus strains have shown anti-
mutagenic activities. However, there is no evidence yet that probiotics can protect against 
the development of colon cancer in humans [64,65]. Although, it is hypothesized that the 
strains tested may have anti-carcinogenic effects by reducing the activity of the enzyme β-
glucuronidase. 
5. Helicobacter pylori 
It is a common chronic bacterial infection in humans, which causes many problems, such as 
chronic gastritis, septic ulcers and gastric cancer. Probiotics like L. salivarius, L. casei Shirota 
and L. acidophilus appear to be promising in inhibiting the growth of H. pylori in vitro 
[66,67]. Moreover, L. johnsonii was also shown effective to inhibit H. pylori [68]. 
6. Lactose intolerance 
It is the most common disorder of the intestinal carbohydrate digestion. In both adults and 
children it has been shown that probiotics can improve the lactose digestion by reducing the 
intolerance symptoms and slowing orocecal transit [69,70]. 
7. Blood cholesterol 
Recently it has been suggested that some strains of probiotic bacteria, like L. acidophilus, L. 
plantarum and Enterococcus faecium could significantly reduce blood cholesterol and increase 
resistance of low density lipoprotein oxidation, leading to decrease of blood pressure [50-52].  
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8. Other disorders 
The majority of probiotics use has focused on diseases related to the gut, but there are 
studies that evaluated probiotics, in allergic conditions, including atopic dermatitis, rhinitis, 
bacterial vaginosis and food allergies [53,71]. 
a. Atopic Dermatitis. It is the most common of the chronic skin disorders, known as 
eczema. Investigations have shown that probiotics like L. rhamnosus GG, can 
prevent or reduce the symptoms [42]. Even eczema can be prevented if mothers 
ingest probiotics during pregnancy and neonatals ingest them during the first 6 
months of their life [53]. 
b. Bacterial Vaginosis. Probiotics (L. rhamnosus GR-1 and L. fermentum RC-14) are 
considered to have theraupetic benefits in vaginosis. Probably this is due to the 
large numbers of lactobacilli in the healthy vaginal microflora [72,73]. 
c. Other ailments. Probiotics such as Lactococcus, Pediococcus and Leuconostoc can 
prevent or limit mycotoxinogenic mould growth [74-78]. Moreover, LAB according 
to their bacterial strain could bind aflatoxin B1 both in vivo and in vitro [79]. It was 
reported in studies that L. paracasei ST11 reduced body and abdominal fat [80]. 
These probiotic bacteria seemed to have an anti-obese action. Probably intestinal 
bacteria may regulate body weight by affecting the host’s metabolic 
neuroendocrine and immune functions [80]. Additionally, probiotics may have 
anticariogenic effects, preventing and treating dental caries and generally be 
effective in the oral cavity and the treatment of periodontal disease [81,82].  
3. Lactic acid bacteria as source of starter cultures 
3.1. Starter cultures and functional starter cultures in fermentation of foods 
LAB for a long time have been applied as starter cultures in fermented foods and beverages, 
because they can improve nutritional, organoleptic, technological and shelf-life characteristics 
[83,84]. LAB initiate rapid and adequate acidification in the raw materials, through the 
production of various organic acids from carbohydrates. Lactic acid is the most abundant, 
followed by acetic acid, whilst LAB can also produce ethanol, bacteriocins, aroma compounds, 
exopolysaccharides and some enzymes [85]. Earlier the production of fermented foods and 
beverages was obtained on a spontaneous fermentation, due to the microflora naturally 
present on the raw materials. Later on, the direct addition of selected starter cultures to the 
food matrix was preferred by the food industry. The advantages were the high degree of 
control over the fermentation process and the standardization of the final product [84]. 
As starter culture can be defined a microbial preparation of a large number of one or more 
microorganisms which is introduced to a raw material aiming to produce a fermented food 
by accelerating and steering its fermentation process [86,87]. 
The industries of fermented foods mainly utilize commercial starter cultures for the direct 
inoculation to the food matrix, which are available as frozen and freeze dried concentrates 
or lyophilized preparations [88]. 
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Recently the use of functional starter cultures in food and beverage fermentation is being 
explored. These cultures have at least one functional property, contributing in the 
improvement of the fermentation process, enhancing the quality and of the end safety 
product and conferring health benefits [84]. Nevertheless, the selection of starter cultures 
must also eliminate undesirable side effects like the formation of D-lactic acid or a racemate 
of lactic acid (DL) or the formation of biogenic amines [84,89]. 
3.2. Probiotics as functional starter cultures 
A category of successful starter cultures are LAB produced probiotic cultures. Firstly, 
Metchnikoff [90] discovered the beneficial effects of LAB on human health, through the 
consumption of yoghurts and fermented milks. Currently probiotic cultures are used for a 
number of products such as yoghurt, yoghurt drinks, infant formulas, dietary supplements, 
etc [91]. Yoghurt is manufactured using Streptococcus thermophilus and Lactobaccilus 
delbrueckii subsp. bulcaricus as starter cultures [17]. 
A manufacture in order to choose any probiotic microbial strain to be used as starter culture 
or better as a blend with a traditionally used starter culture (co-culture), must check the 
following aspects [92]: 1) The ability of the probiotics to grow in a medium to increase the 
cells counts. 2) The robustness of the organism to withstand the freezing and drying stages 
of preparation. 3) The tolerance to acidity of the gastric acid and the bile salts during their 
passage in the gastrointestinal tract. Thus, the probiotic strains must be stable in order to 
claim the health benefits [92].  
LAB are used as starter cultures either in dairy or non-dairy products (Table 2). 
 
Genus Application in dairy foods Application in non-dairy 
foods 
Lactobacillus spp Cultured dairy products, 
cheese, yoghurt, kefir 
Sausage, sourdough bread, 
fermented vegetables 
Lactococcus spp Cheese, butter milk sour 
cream, cultured dairy 
products 
- 
Leuconostoc spp Cheese, cultured dairy 
products, sour cream, 
buttermilk 
Fermented vegetables 
Streptococcus thermophilus Cheese, yoghurt  - 
Pediococcus - Sausage, fermented 
vegetables 
Tetragenococcus - Soy sauce 
Oenococcus - Wine 
Table 2. Lactic acid bacteria used as starter cultures in fermented foods 
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3.3. Functional starter cultures in fermented dairy products 
Traditionally, LAB have been used in the fermentation of dairy products, as a simple and 
safe way of preserving such foods. The main species of LAB that can potentially be used as 
probiotic cultures in dairy products belong to the Lactobacillus spp (L. acidophilus, L. lactis, L. 
casei, L. plantarum, L. rhamnosus, L. reuteri, L. delbrueckii subsp. bulgaricus) or to the 
Enterococcus spp. (E. faecalis, E. faecium) [17,92]. 
Dairy products are considered as ideal vehicles for delivering probiotics to the human gut. 
Yoghurt is considered the most important, followed by cultured buttermilk, kefir, cheeses, 
ice-cream [17,22,92] or frozen desserts like chocolate mousse [93]. Moreover proteolytic 
strains of LAB produced probiotics are used to release bioactive peptites called angiotensin 
I-converting enzyme inhibitors, which are examined for their hypotensive role [94]. 
Furthermore interaction between probiotics and starter cultures are possible, either as 
synergism (e.g. yoghurt) or antagonism (e.g. bacteriocins which exhibit antibiotic properties) 
[20].  
A minimum viable LAB count of 106 CFU/g in fermented dairy food is recommended for the 
claimed health benefits [95]. 
3.4. Functional starter cultures in fermented non-dairy products 
3.4.1. Fermented meat and meat products 
The preservation of meat and meat products by fermentation has been used from ancient 
times and it was based mainly on natural meat microorganisms. Recently, researchers begun 
to develop starter cultures for meat products, in order to ensure standard quality for the 
fermentation process [87]. In 1995 the first LAB meat starter culture used by Niven et al. [96] 
in the USA was a pure culture of Pediococcus cerevisiae. Essential requirements of meat LAB 
starter cultures are the immediate and rapid production of organic acids at the start of the 
fermentation, which will result in a pH below 5.1 [97]. Therefore, the original characteristics 
of the foods are changed, resulting in enhancement of the final products [98].  
As commercial meat LAB starter cultures the species more used belong to the Lactobacillus 
and Pediococcus strains, which can be isolated from dry sausages [97], sauerkraut [20], or 
smoked salmon [99]. Strains of the above LAB were found to have the best survival activity 
under acidic conditions and high levels of bile salts [98]. The role of the starter culture as 
aforementioned is for the safety of foods by inactivating pathogens and spoilage 
microorganisms via the acid and bacteriosin production. Therefore, the production of 
biogenic amines is inhibited and microbial growth is suppressed, without the use of 
antibiotics [97].  
Several studies have reported that LAB from meat and meat products can have antibiotic 
resistance [100]. Thus, before using novel starter cultures or probiotic cultures it is important 
to check that they do not contain transferable resistance genes [97]. In addition, the selection 
of LAB starter cultures for sausage production must not have amino decarboxylase activity. 
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Otherwise, biogenic amines will be produced in foods, such as histamine, tryptamine, 
tyramine, cadaverine, putrescine and phenylethylamine which have toxic effects [101]. 
3.4.2. Fermented vegetables 
LAB fermentation of vegetables can be achieved due to the presence of carbohydrates. 
Usually fermented vegetable juices are produced from cabbage, red beet, carrot, celery and 
tomato [18,102]. Also, LAB play an important role in pickles and table olives fermentation, 
affecting the final flavour and shelf-life [103,104]. 
3.4.3. Starter cultures in silages 
Ensiling is a traditional method of preserving forages and is widely used all over the world. 
It is based on natural fermentation, where LAB ferment water-soluble carbohydrates into 
organic acids, mainly lactic acid or acetic and formic acids, under anaerobic conditions. 
Inoculation of LAB is often used as silage additive to enhance lactic acid fermentation [18]. 
This results in decreasing pH, inhibiting detrimental anaerobes and preserving the 
nutritional value and palatability of the forage [105,106]. 
Among the LAB genera frequently used are Lactobacillus plantarum, Enterococcus faecium, 
Pediococcus acidilactici, Pediococcus pentoseceus and Lactobacillus acidophilus, with usual rates 
105-106 viable cells / g [107]. Feeding ruminants with silages that have been treated with LAB 
beyond improving their performance, it is believed to induce probiotic effects [108].  
4. Lactic acid bacteria as source of antimicrobial agents 
LAB derived probiotic bacteria display a wide range of antimicrobial activities. Some strains 
of LAB produce non specific antimicrobial substances (short chain fatty acids, hydrogen 
peroxide) while others produce toxins (bacteriosins, bacteriosin-like components) [109]. 
Short chain fatty acids (formic, acetic, propionic, butyric and lactic acids) which are 
produced during the anaerobic metabolism of carbohydrates, decrease the pH. It has been 
considered that these acids are responsible for the domination of mucosal ecosystems by 
LAB [110]. Also, hydrogen peroxide inhibits the growth of pathogens [111].  
4.1. Bacteriocins 
Most of bacteriocins originating by Gram positive bacteria are produced from LAB. They are 
proteins that have bacteriocidal activity against species closely related to the bacteriocin 
producing strains, which could be applied in food preservation and health care [112,113]. 
Traditionally bacteriocin production has been considered an important characteristic in the 
selection of probiotic strains, while nowadays it is considered that they may function within 
the gastrointestinal tract [114], perhaps as alternatives to antibiotics for medical and veterinary 
use [115]. Generally bacteriocins are cationic peptides which display hydrophobic or 
amphilitic properties and usually the bacterial membrane is the target for their action [116]. 
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The majority of bacteriocin produced by LAB are distinguished from classical antibiotics 
because: a) They are ribosomally synthesized and have a relatively narrow killing spectrum. 
b) They can be divided into two main groups, produced by Gram-negative and Gram-
positive bacteria [117,118]. 
Bacteriocins according to their structure and characteristics can be classified mainly in the 
following classes: 
 Class I (lantibiotics), small peptides [119]. 
 Class II, small heat-stable proteins which are further divided into subclasses such as IIa 
(pediocin-like bacteriocins) and IIb (two peptite bacteriocins) [119]. 
 Class III (helveticin) [120]. 
Bacteriocins mainly produced by Lactobacillus acidophilus have strong antimicrobial 
capacity against various food pathogens [113]. Bacteriocins can act as bactericidal or 
bacteriostatic, a distinction which is strongly dependent on bacteriocin dose and degree of 
purification, physiological state of the indicator cells and experimental conditions such as 
incubation temperature, pH, presence of agents disrupting cell wall integrity, etc 
[121,122].  
4.2. Traits of LAB derived bacteriocins 
LAB derived bacteriocins are suitable to use as food preservatives due to their 
characteristics: a) protein nature – they are inactivated by proteases in the gastrointestinal 
tract. b) Non-toxic and generally non-immunogenic. c) Thermoresistant thus the 
antimicrobial activity remains after pasteurization and sterilization. d) Affect most of the 
Gram-positive bacteria. e) Genetic determinants generally located in plasmid facilitating 
genetic manipulation to increase the variety of natural peptides. f) Usually act on the 
bacterial cytoplasmic membrane having no cross resistance with antibiotics [122,123]. 
Some benefits of the use of bacteriocins as food preservatives are: a) extended shelf-life of 
foods. b) reduction of the risk of transmission of food born pathogenic bacteria. c) 
Amelioration of economic losses due to food spoilage. d) No addition of chemical 
preservatives. e) Decrease of the intensity of heat treatments resulting in better preservation 
of food nutrients and sensory properties of the food. f) Marketing of “novel” foods, less 
acidic, less salty and with higher water content [123].  
Nicin (lantibiotic – class I) is the first bacteriosin produced by LAB (Lactococcus lactis) whilst 
today it is used in many countries as biopreservatives in foods [109]. Nicins have a dual 
mode of action: a) Binding to lipid II thus preventing correct cell wall synthesis and b) 
employing lipid II as a docking molecule to initiate a process of membrane insertion and 
pore formation which leads to rapid cell death [109]. Nisin-producing bacteria can be found 
in about 30% of human milk samples. This substance may protect mothers from mastitis and 
infants from toxication by pathogenic skin flora like Staphylococcus aureus [124]. Except 
from nicin, currently pediocin PA-1/AcH from several Pediococcus strains and enterocin 
AS-48 from Enterococcus faecalis are used as biopreservatives [119].  
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There are at least three ways in which bacteriocins can be incorporated into a food to 
ameliorate its safety: a) By using a purified or semi-purified bacteriocin preparation as food 
ingredient. b) By introducing an ingredient that has earlier been fermented with a 
bacteriocin producing strain. c) By using a bacteriocin-producing culture in fermented 
products to produce the bacteriocin in situ [125]. 
Additionally, bacteriocin production can contribute to the probiotic functionality of intestinal 
LAB, while in certain cases may be directly responsible for it, with respect to either beneficially 
modulating the gut microbiota or inhibiting some gastrointestinal pathogenic bacteria [30]. 
Consequently bacteriocins, derived from LAB can cover a broad field of applications, 
including the food industry and the medical sector, mainly in combination with other 
treatments to increase their effectiveness in humans and animals [126]. In the latter, 
bacteriocins can be used as growth promoters, instead of antibiotics, which have been 
banned in the European Union since 2006 [127]. 
5. Lactic acid bacteria as source of vitamins 
Human life cannot exist without vitamins, because they are involved in essential functions 
e.g. cell metabolism and antioxidant activities. Humans cannot synthesize most of these 
vitamins, although it is well known that some intestinal bacteria like LAB can produce some 
vitamins (folate, vitamin B12 or cobalamin, vitamin K2 or menaguino, riboflavin and 
thiamine) [128,129]. The gut microbiota has been recognized as a source of some water-
soluble vitamins, while such vitamins have also been reported as results of the LAB 
fermentation in yogurt, cheeses and other fermented foods. 
5.1. Folate 
Folate is the term used to describe the folic acid derivatives, such as the folyl glutamates 
which are naturally present in foods and folic acid that is the chemically synthesized form of 
folate, commonly used for food fortification and nutritional supplements. Folate belongs to 
the B-group of vitamins and participates in many metabolic pathways like the biosynthesis 
of DNA and RNA and the inter-conversions of amino acids. Moreover, folate possesses 
antioxidant capacity that protects the genome by preventing free radical hack of DNA [130]. 
Dietary folate is essential for humans, since it cannot be synthesized by mammalian cells. 
Folate can be found in legumes, leafy greens, some fruits and vegetables, in liver and 
fermented dairy products [131], especially in yogurts, where it may be increased depending 
on the starter cultures used and the storage condition, to values above 200 μg / lt [132]. 
Epidemiological studies indicated that folate deficiency is associated with a variety of 
disorders like Alzheinmer’s disease, coronary heart diseases, osteoporosis and increased risk 
of breast and colorectal cancer [130,133]. 
LAB having the ability to produce folate belong to the Lactobacillus spp (L. lactis, L. plantarum, 
L. bulgaricus), Streptococcus spp. and Enterococcus spp. Nevertheless, some lactobacilli strains 
(L. gasseri, L. salivarius, L. acidophilus and L. johnsonii) used as both starter cultures and 
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probiotics, cannot synthesize folate due to their lacking in some genes involved in folate 
biosynthesis [130]. Furthermore, it has been reported that some starter cultures and 
probiotic lactobacillus strains in non-dairy foods utilize more folate than they produce 
[128,130]. For this reason nowadays the food industry focuses on the strategy to select and 
use folate producing probiotic strains, to produce fermented products with elevated 
amounts of “natural” folate concentrations, without increasing production cost, although 
increasing health benefits [130,133].  
5.2. Vitamin B12 
Vitamin B12 or cobalamin is required for the metabolism of fatty acids, amino acids, nucleic 
acids and carbohydrates [134]. Vitamin B12 cannot be synthesized by mammals and must be 
obtained from exogenous sources like foods or the intestinal microbiota [128]. It has been 
reported that among the microorganisms some members of the Lactobacillus spp have the 
ability to produce this vitamin. In particular a probiotic strain of L. reuteri which exhibits 
hypocholesterolaemic activity in animals can produce B12 [135]. 
Vitamin B12 deficiency can cause various pathological disorders that affect the 
haematopoietic (pernicious anaemia), nervous and cardiovascular system. Furthermore, this 
deficiency in male animal models influenced the number of offspring which showed growth 
retardation and decrease in some blood parameters [136]. 
5.3. Vitamin K 
Vitamin K is involved in blood clotting, tissue calcification, atherosclerotic plaque and bones 
and kidneys function [137]. Vitamin K is present as phylloquinone (Vitamin K1) in green 
plants and as menaquinone (K2) produced by some intestinal bacteria, like LAB and 
especially strains of the genera Lactococcus, Lactobacillus, Enterococcus, Leuconostoc and 
Streptococcus [128]. Vitamin K deficiency has been involved in some clinical disorders like 
intracranial hemorrhage in newborn infants and possible bone fracture resulting from 
osteoporosis [129]. LAB producing menoquinone could be useful to supplement vitamin K 
requirements in humans [138]. 
5.4. Riboflavin 
Riboflavin or vitamin B2 is necessary in cellular metabolism, being the precursor of 
coenzymes acting as hydrogen carriers in biological redox reactions [129]. Although, 
riboflavin is present in many foods such as dairy products, meat, eggs, green vegetables, its 
deficiency occurs with damages in the liver, skin and changes in the brain glucose 
metabolism [128,129], with symptoms like hyperaemia, sore throat, odema of oral and 
mucous membranes, cheilosis and glossitis [139]. 
Currently, riboflavin-producing LAB strains were isolated and used as a convenient 
biotechnological application for the preparation of bread (fermented sourdough) and pasta 
to enrich them with vitamin B2 [140]. 
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6. Lactic acid bacteria as source of enzymes 
LAB possess an extensive collection of enzymes many of which have the potential to 
influence the composition and the processing, organoleptic properties and quality of foods 
and feeds. LAB release various enzymes into the gastrointestinal tract and exert potential 
synergistic effects on digestion and alleviate symptoms of intestinal malabsorption [141]. In 
other cases these organisms may serve as a source for the preparation of enzyme extracts 
that are able to function under the environmental conditions of fermentation [142]. The 
enzymatic activity has been studied mainly in LAB isolated from wine or other fermented 
foods like cheeses and yoghurt [143,144]. Species of Lactococcus and Pediococcus are the LAB 
most commonly associated with fermented foods [143]. The LAB produced enzymes and in 
particular amylases which are the most stable can be used in sourdough technology for the 
natural improvement of bread texture [145]. Moreover, LAB contribute to the aroma and 
flavor of fermented foods. Certain peptidases produced by Lactococcus lactis subsp. cremoris 
improved the sensory quality of cheese [146]. In addition, proteolysis and lipolysis may 
enhance the flavour of most varieties of cheese [147]. LAB strains isolated from a traditional 
Spanish Genestoso cheese were evaluated for the enzymatic activity and it was reported that 
dipeptidase activity of high level was found for Lactococcus spp, enterolytic activity was 
detected for Enterococcus spp., while carboxypeptidase activity was very low or undetectable 
[147]. 
Also, enzymes play an important role in winemaking. Wine flavor and aroma apart from 
aromas originating in grapes and alcoholic fermentation, is derived mainly from the activity 
of the LAB, through the action of their enzymes. These bacteria grow in wine during 
malolactic fermentation, following alcoholic fermentation, while a broad range of secondary 
modifications improve the taste and flavor of wine [144]. 
7. Lactic acid bacteria as source of exopolysaccharides 
7.1. Definition and classification of exopolysaccharides 
A number of LAB can produce a variety of long chain sugar polymers, called 
exopolysaccharides (EPS) which are mainly employed for the production of fermented dairy 
products. They are synthesized either extracellularly from sucrose by glycansucrases or 
intracellularly by glycosyltransferases from sugar nucleotide precursors [148]. These EPS 
can be classified according to their chemical composition and biosynthesis mechanism as 
homopolysaccharides, consisting of a single type of monosaccharide and 
heteropolysaccharides consisting of repeating units of two or more types of 
monosaccharides, substituted monosaccharides and other units like phosphate, acetyl and 
glycerol [149-151].  
Homopolysaccharides are further divided into fructans including levan and inuline-type 
and glucans including dextran, mutan, alteran and b-1, 3 glucan [152]. On the other hand, 
heteropolysaccharides demonstrate little structural similarity to one another. Their 
production is influenced by the bacterial growth, phase, medium composition (carbon and 
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nitrogen source), pH and temperature [153]. They can be produced by Lactococcus spp. and 
Lactobacillus spp. and they play a crucial role in the food industry [151]. 
Homopolysaccharides can be introduced in sourdough products, influencing the structural 
quality and backing ability in bakery products, while heteropolysaccharides are used as 
food additives in dairy products [154]. EPS contribute to the organoleptic quality of the 
fermented foods, in texture, taste perception, mouth-feel and stability [153,155]. The above 
researchers reported that there is no information about the effects of bacterial EPS in non-
dairy foods, such as meat products, sauerkraut and vinegar. Although EPS are tasteless, 
they prolong the time that the milk product spends in the mouth, enhancing its delicacy 
through an improved volatilization of the intrinsic flavors [153,155].  
7.2. Applications of exopolysaccharides in the industry 
In the last years, EPS derived from LAB have received increasing interest because of their 
GRAS status and their properties. EPS can improve the rheology of fermented foods (viscosity 
and elasticity) as natural biothickeners, emulsifiers, gelling agents and physical stabilizers to 
bind water and limit syneresis [153,156]. In particular commercial products like LAB dextran 
could be utilized apart from foods in gel filtration products, in the pharmaceutical industry, as 
blood volume expander and flow improver, in chemistry as paper and metal plating 
processes, in enhanced oil recovery and in chromographic media. Furthermore, levan can find 
use in the food industry as biothickener, while alteran as low-viscocity factor, extender, etc 
[128,151,157]. Additionally, EPS may produce oligosaccharides having prebiotic properties 
that could find important applications in functional foods [158]. The successful application of 
EPS in the manufacture of fermented milks is determined by the ability to bind water, interact 
with proteins and increase the viscosity of the milk serum phase [159]. Although, many LAB 
strains are able to produce EPS, their yield is low [149] and their industrial applications for the 
improvement of the properties of food products are limited [155]. 
7.3. Potential health benefits of exopolysaccharides 
Apart from the technological benefits some EPS derived from LAB are claimed to have 
beneficial physiological effects on consumer’s health. These benefits are detectable at very 
low concentrations [153]. The EPS due to their increased viscosity in foods may remain for 
longer time in the gastrointestinal tract and therefore be beneficial to the transient 
colonization by probiotic bacteria [153,160]. Another health benefit is the generation of short 
chain fatty acids by colonic microflora degradation in the gut. Several of these fatty acids are 
possibly involved in the prevention of colon cancer [153,159]. In addition, LAB synthesized 
EPS appear to have anti-tumor, anti-ulcer, immuno-modulating and cholesterol-lowering 
activity [155]. 
7.4. Factors limiting the use of exopolysaccharides 
The EPS used in the industry represent only a small fraction of the biopolymers used. The 
reasons are their economical production which needs a global knowledge of their 
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biosynthesis and an adapted bioprocess technology [151]. Moreover, large scale production 
of LAB derived EPS is low, since LAB being anaerobes, are relatively inefficient in 
converting energy from carbohydrates, compared to aerobes [149,161]. So this technological 
barrier must be overcome for cost effective production of EPS. Furthermore, the genetic 
instability of EPS production is a problem to industrial applications, resulting in loss or 
reduction of production or change in the composition of EPS [162].  
Increasing the knowledge on EPS structure may lead to the production of the “designer” 
EPS, including the modification primary in structure by altering their physical properties, 
their function and their production levels. However, for such production of EPS legal 
approval and the acceptance by the consumers and the food industries are required 
[151,163]. However, if these biomolecules are to be developed commercially, they must be 
cost effective. 
7.5. Negative effects of exopolysaccharides 
In some circumstances EPS cause food spoilage. For instance during the fermentation of 
wine or cider the final products receive undesirable properties. The EPS synthesis is 
responsible for dental plaque that results in dental caries. Moreover, the accumulation of 
EPS cause many technical and hygienic problems in the cheese and milk industries 
[156,164]. 
8. Lactic acid bacteria as source of low-calorie sweeteners 
Recently, low calorie sugars produced from LAB have attracted the interest of researchers, 
industries and consumers, since they can find application as vital food ingredients mainly in 
foods marketed as “diabetic foods”, like sugar-free candies, cookies and chewing gums 
[165,166]. Manitol, sorbitol, xylitol, tagatose and thehalose are sweeteners produced by LAB. 
These substances are polyols, i.e. sugar alcohols and can be produced in food fermentation 
processes. They can be incorporated directly to foods or be produced in the food by LAB, 
leading to the production of foods containing such sweeteners [165]. Leuconostoc and 
Lactobacillus spp. seem to be the most promising producers of these sweeteners [167,168].  
A number of health benefits have been attributed to these LAB produced low calories 
sweeteners, like low glycemic index, osmotic diuretics, weight control, antiplaque, prebiotic. 
These GRAS substances could be used especially by children, diabetic patients and weight 
watchers [165,166]. 
9. Conclusion 
Lactic acid bacteria are very promising sources for novel products and applications, 
especially those that can satisfy the increasing consumer’s demands for natural products 
and functional foods. They can be used in the diet of humans and animals, with particular 
role in their health status. Despite recent advances, the study of LAB and their functional 
ingredients is still an emerging field of research that has yet to realize its full potential. 
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